Biofil Chemicals & Pharmaceuticals share news, announcements and annual reports
NSE: BIOFILCHEMBSE: 524396Pharmaceuticals & BiotechnologySmall Cap
Biofil Chemicals & Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1994 on BSE, Jun 1996 on NSE
Last close ₹28.68down ₹0.73 (2.48%)BSE ₹29.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹29.41.
30 Oct: open ₹29.00, high ₹29.80, low ₹28.26
52-week range of traded prices to 30 Oct 2026
₹25.60Low, 30 Mar 2026₹46.34High, 3 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹47 Cr3,363rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 96.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.16
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 2.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,71974.4% delivered
Biofil Chemicals & Pharmaceuticals share news and announcements
403 announcements, routine notices left out, newest first. Page 7 of 9.
Oct 2016
Sep 2016
30 Sep · Regulation 44(3) of SEBI (LODR), Reg., 2015
Aug 2016
24 Aug · Meeting
10 Aug · Board meeting
May 2016
Apr 2016
Feb 2016
13 Feb · Board meeting
Jan 2016
Nov 2015
Oct 2015
Sep 2015
28 Sep · Disclosure of Voting Pattern - Clause 35A
Aug 2015
13 Aug · Board meeting
May 2015
30 May · Results
Apr 2015
Feb 2015
3 Feb · Board meeting
To take on record and approve the following matters : 1. Un-audited Financial Results of the Company for the quarter ended on December 31, 2014.
Nov 2014
4 Nov · Board meeting
To take on record and approve the following matters : 1.Un-audited Financial Results of the Company for the quarter ended September 30, 2014.
Aug 2014
22 Aug · Meeting
Company has fixed Book Closure from September 20, 2014 to September 23, 2014 (both days inclusive) for the purpose of Annual General Meeting scheduled to be held on September 23, 201419 Aug · Updates
Company has created a separate email address for Corporate Compliance and for redressing shareholder grievances, new email address of the Company is bcplcompliance@gmail.com.4 Aug · Board meeting
To take on record and approve the following matters: 1.Un-audited Financial Results of the Company for the quarter ended June 30, 2014. 2. To consider and fix the Notice of Annual General Meeting and Book closure date for the financial year ended March 31, 2014. 3. To fix the cut-off date to record the entitlement of the shareholders to cast their vote electronically at the ensuing AGM by electronic means under the Companies Act, 2013 and rules made there under. Further, in terms of provisions of the Company's Code of Conduct for Prevention of Insider Trading (Code) the "Trading Window" for trading in equity shares of the Company shall remain closed from August 4, 2014 to August 15, 2014 for all the Designated employees and Directors of the Company for the purpose approval quarterly financial statement for the quarter ended June 30, 2014.
May 2014
30 May · Results
20 May · Board meeting
To transact the following matters along with other routine matters: 1) To consider and approve the Audited Financial Results for the Quarter as well as year ended March 31, 2014. 2) Any other matter with the permission of the chair. Further, in terms of provisions of the Company's Code of Conduct for Prevention of Insider Trading (Code), the "Trading Window" for trading in the equity shares of the Company shall remain closed from May 16, 2014 to June 02, 2014, for all the designated employees and Directors of the Company for the purpose approval quarterly as well Annual financial statement.
Feb 2014
11 Feb · Results
4 Feb · Board meeting
To take on record the Un-audited Financial Results of the Company for the quarter ended on December 31, 2013 along with other routine business.
Dec 2013
11 Dec · Results
Nov 2013
11 Nov · Board meeting
To take on record and approve the Un-audited Financial Results of the Company for the quarter ended on September 30, 2013 along with other routine business.
Oct 2013
Aug 2013
26 Aug · Corporate action
Company has fixed the Book Closure from September 23, 2013 to September 28, 2013 for the purpose of Annual General Meeting and Complying of provisions of listing agreement.